InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by Dahlquist Karl S., Directeur Juridique. Director active across 1 companies, notably AtriCure, Inc.. Cumulatively, 5 filings have been logged. The latest transaction was disclosed on 1 March 2022 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations5 total
07,789 shares0
Common Stock
SEC:0001323885-22-000023:0·
€1,25224 shares@ €52.18530.0001% mcap7.1% of flow
Common Stock
SEC:0001209191-22-000384·
€1,25224 shares@ €52.18530.0001% mcap3.5% of flow
Common Stock
SEC:0001209191-22-000384:0·
€16,504428 shares@ €38.56020.0012% mcap92.9% of flow
Common Stock
SEC:0001209191-21-044872·
€16,504428 shares@ €38.56020.0012% mcap46.5% of flow
Common Stock
SEC:0001209191-21-044872:0·
5 of 5 declarations
About Dahlquist Karl S.
Karl S. Dahlquist is the Chief Legal Officer of AtriCure, Inc. In this role, he is responsible for overseeing the company's legal affairs, including regulatory compliance and risk management. Dahlquist plays a crucial role in protecting AtriCure's legal interests, ensuring that the company adheres to applicable laws and regulations. His expertise in business law is a valuable asset to the organization.
